Capital Fund Management S.A. Abiomed Inc Call Options Transaction History

Capital Fund Management S.A.

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 13, 2020	BUY	$130.51 - $196.01 $143,561 - $215,611	1,100 Added 37.93%	4,000 $580,000
Q4 2019 Feb 13, 2020	SELL	$159.31 - $223.54 $828,412 - $1.16 Million	-5,200 Reduced 64.2%	2,900 $495,000
Q3 2019 Nov 13, 2019	BUY	$175.89 - $279.23 $369,369 - $586,383	2,100 Added 35.0%	8,100 $1.44 Million
Q2 2019 Aug 12, 2019	BUY	$250.96 - $284.94 $1.3 Million - $1.48 Million	5,200 Added 650.0%	6,000 $1.56 Million
Q1 2019 May 13, 2019	SELL	$276.39 - $362.25 $2.54 Million - $3.33 Million	-9,200 Reduced 92.0%	800 $228,000
Q4 2018 Feb 13, 2019	BUY	$281.08 - $444.25 $28,108 - $44,425	100 Added 1.01%	10,000 $3.25 Million
Q3 2018 Nov 14, 2018	BUY	$354.53 - $449.75 $1.77 Million - $2.25 Million	5,000 Added 102.04%	9,900 $4.45 Million
Q2 2018 Aug 14, 2018	BUY	$278.07 - $446.21 $973,245 - $1.56 Million	3,500 Added 250.0%	4,900 $2 Million
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $269,486 - $414,190	1,400 New	1,400 $407,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.